Metabolic and functional evaluation of the heart and lungs in pulmonary hypertension by gated 2-[18F]-Fluoro-2-deoxy-D-glucose positron emission tomography

Pulmonary Circulation

Volumn 7, Issue 2, 2017, Pages 428-438

  Saygin, Didem ^a   Highland, Kristin B ^a   Farha, Samar ^a   Park, Margaret ^a   Sharp, Jacqueline ^a   Roach, Emir Charles ^a   Tang, W H Wilson ^a   Thomas, James D ^b   Erzurum, Serpil C ^a   Neumann, Donald R ^a   DiFilippo, Frank P ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Cardiac PET; Lung PET; PET; Positron emission tomography; Pulmonary hypertension

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; FLUORODEOXYGLUCOSE F 18;

ADULT; ARTICLE; CLINICAL ARTICLE; COMPUTED TOMOGRAPHY SCANNER; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DOPPLER ECHOCARDIOGRAPHY; DRUG UPTAKE; ENERGY YIELD; FEMALE; GLUCOSE TRANSPORT; GLYCOLYSIS; HEART CATHETERIZATION; HEART FUNCTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART MUSCLE METABOLISM; HEART RATE; HEART RIGHT VENTRICLE EJECTION FRACTION; HEART RIGHT VENTRICLE ENDDIASTOLIC VOLUME; HUMAN; IMAGE ANALYSIS; IMAGE PROCESSING; IMAGE QUALITY; IMAGE RECONSTRUCTION; LUNG ARTERY PRESSURE; LUNG FUNCTION; LUNG METABOLISM; MALE; NEW YORK HEART ASSOCIATION CLASS; POSITRON EMISSION TOMOGRAPHY; PULMONARY ARTERY OCCLUSION PRESSURE; PULMONARY HYPERTENSION; RADIOLOGICAL PARAMETERS; RR INTERVAL; SIX MINUTE WALK TEST; STANDARDIZED UPTAKE VALUE; SYSTOLIC BLOOD PRESSURE; TISSUE METABOLISM; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

EID: 85021276270     PISSN: 20458932     EISSN: 20458940     Source Type: Journal    
DOI: 10.1177/2045893217701917     Document Type: Article

References (21)

1. Ruiter G, Ying Wong Y, de Man FS, et al. Right ventricular oxygen supply parameters are decreased in human and experimental pulmonary hypertension. J Heart Lung Transplant 2013; 32: 231–240.
2. Akasaka T, Yoshikawa J, Yoshida K, et al. Comparison of relation of systolic flow of the right coronary artery to pulmonary artery pressure in patients with and without pulmonary hypertension. Am J Cardiol 1996; 78: 240–244.
3. Lundgrin EL, Park MM, Sharp J, et al. Fasting 2-deoxy-2- [18F]fluoro-D-glucose positron emission tomography to detect metabolic changes in pulmonary arterial hypertension hearts over 1 year. Ann Am Thorac Soc 2013; 10: 1–9.
4. Can MM, Kaymaz C, Tanboga IH, et al. Increased right ventricular glucose metabolism in patients with pulmonary arterial hypertension. Clin Nucl Med 2011; 36: 743–748.
5. Piao L, Fang YH, Cadete VJ, et al. The inhibition of pyruvate dehydrogenase kinase improves impaired cardiac function and electrical remodeling in two models of right ventricular hypertrophy: resuscitating the hibernating right ventricle. J Mod Med (Berl) 2010; 88: 47–60.
6. Sutendra G, Dromparis P, Paulin R, et al. A metabolic remodeling in right ventricular hypertrophy is associated with decreased angiogenesis and a transition from a compensated to a decompensated state in pulmonary hypertension. J Mod Med (Berl) 2013; 91: 1315–1327.
7. Graham BB, Kumar R, Mickael C, et al. Severe pulmonary hypertension is associated with altered right ventricle metabolic substrate uptake. Am J Physiol Lung Cell Mol Physiol 2015; 309: L435–440.
8. Xu W, Koeck T, Lara AR, et al. Alterations of cellular bioenergetics in pulmonary artery endothelial cells. Proc Natl Acad Sci USA 2007; 104: 1342–1347.
9. Marsboom G, Wietholt C, Haney CR, et al. Lung 18F-fluorodeoxyglucose positron emission tomography for diagnosis and monitoring of pulmonary arterial hypertension. Am J Respir Crit Care Med 2012; 185: 670–679.
10. Zhao L, Ashek A, Wang L, et al. Heterogeneity in lung (18)FDG uptake in pulmonary arterial hypertension: potential of dynamic (18)FDG positron emission tomography with kinetic analysis as a bridging biomarker for pulmonary vascular remodeling targeted treatments. Circulation 2013; 128: 1214–1224.
11. Hagan G, Southwood M, Treacy C, et al. (18)FDG PET imaging can quantify increased cellular metabolism in pulmonary arterial hypertension: A proof-of-principle study. Pulm Circ 2011; 1: 448–455.
12. Chen DL, Cheriyan J, Chilvers ER, et al. Quantification of lung PET images: challenges and opportunities. J Nucl Med 2017; 58: 201–207.
13. Chen DL, Mintun MA and Schuster DP. Comparison of methods to quantitate 18F-FDG uptake with PET during experimental acute lung injury. J Nucl Med 2004; 45: 1583–90.
14. Lang RM, Badano LP, Mor-Avi V, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J AmSoc Echocardiogr 2015; 28: 1–39.
15. Rudski LG, Lai WW, Afilalo J, et al. Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography Endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr 2010; 23: 685–713.
16. Ruiter G, Wong YY, Raijmakers P, et al. Pulmonary 2-deoxy- 2-[(18)F]-fluoro-d-glucose uptake is low in treated patients with idiopathic pulmonary arterial hypertension. Pulm Circ 2013; 3: 647–653.
17. Kluge R, Barthel H, Pankau H, et al. Different mechanisms for changes in glucose uptake of the right and left ventricular myocardium in pulmonary hypertension. J Nucl Med 2005; 46: 25–31.
18. Oikawa M, Kagaya Y, Otani H, et al. Increased [18F]fluorodeoxyglucose accumulation in right ventricular free wall in patients with pulmonary hypertension and the effect of epoprostenol. J Am Coll Cardiol 2005; 45: 1849–1855.
19. Fang W, Zhao L, Xiong CM, et al. Comparison of 18F FDG uptake by right ventricular myocardium in idiopathic pulmonary arterial hypertension and pulmonary arterial hypertension associated with congenital heart disease. Pulm Circ 2012; 2: 365–372.
20. Tatebe S, Fukumoto Y, Oikawa-Wakayama M, et al. Enhanced [18F]fluorodeoxyglucose accumulation in the right ventricular free wall predicts long-term prognosis of patients with pulmonary hypertension: a preliminary observational study. Eur Heart J Cardiovasc Imaging 2014; 15: 666–672.
21. Wang L, Zhang Y, Yan C, et al. Evaluation of right ventricular volume and ejection fraction by gated (18)F-FDG PET in patients with pulmonary hypertension: comparison with cardiac MRI and CT. J Nucl Cardiol 2013; 20: 242–252.